$3.79T
Total marketcap
$140.08B
Total volume
BTC 57.93%     ETH 12.28%
Dominance

Alcon ALC Stock

73.89 USD {{ price }} -0.498253% {{change_pct}}%
Exchange
NYSE
Market Cap
36.91B USD
LOW - HIGH [24H]
73.87 - 74.65 USD
VOLUME [24H]
1.29M USD
{{ volume }}
P/E Ratio
34.20
Earnings per share
2.16 USD

Alcon Price Chart

Alcon ALC Financial and Trading Overview

Alcon stock price 73.89 USD
Previous Close 86.96 USD
Open 88.42 USD
Bid 87.68 USD x 300
Ask 87.76 USD x 300
Day's Range 86.97 - 88.42 USD
52 Week Range 80.48 - 101.1 USD
Volume 1.74M USD
Avg. Volume 1.61M USD
Market Cap 43.2B USD
Beta (5Y Monthly) 0.699
PE Ratio (TTM) 38.82222
EPS (TTM) 2.16 USD
Forward Dividend & Yield 0.33 (0.38%)
Ex-Dividend Date May 14, 2025
1y Target Est 105.79 USD

ALC Valuation Measures

Enterprise Value 47.57B USD
Trailing P/E 38.82222
Forward P/E 24.81534
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 4.353119
Price/Book (mrq) 1.9678742
Enterprise Value/Revenue 4.793
Enterprise Value/EBITDA 20.389

Trading Information

Alcon Stock Price History

Beta (5Y Monthly) 0.699
52-Week Change -3.79%
S&P500 52-Week Change 13.16%
52 Week High 101.1 USD
52 Week Low 80.48 USD
50-Day Moving Average 87.93 USD
200-Day Moving Average 89.77 USD

ALC Share Statistics

Avg. Volume (3 month) 1.61M USD
Avg. Daily Volume (10-Days) 1.69M USD
Shares Outstanding 494.62M
Float 494.6M
Short Ratio 2.74
% Held by Insiders 0.13%
% Held by Institutions 68.26%
Shares Short 4.73M
Short % of Float N/A
Short % of Shares Outstanding 1.06%

Dividends & Splits

Trailing Annual Dividend Rate 0.309
Trailing Annual Dividend Yield 0.35%
5 Year Average Dividend Yield N/A
Payout Ratio 0.1181
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2024
Most Recent Quarter (mrq) March 31, 2025
Next Fiscal Year End December 31, 2025

Profitability

Profit Margin 11.28%
Operating Margin (ttm) 13.30%
Gross Margin 55.57%
EBITDA Margin 23.50%

Management Effectiveness

Return on Assets (ttm) 2.74%
Return on Equity (ttm) 5.22%

Income Statement

Revenue (ttm) 9.93B USD
Revenue Per Share (ttm) 20.06 USD
Quarterly Revenue Growth (yoy) 0.59%
Gross Profit (ttm) 5.52B USD
EBITDA 2.33B USD
Net Income Avi to Common (ttm) 1.12B USD
Diluted EPS (ttm) 2.25
Quarterly Earnings Growth (yoy) 41.09%

Balance Sheet

Total Cash (mrq) 1.41B USD
Total Cash Per Share (mrq) 2.85 USD
Total Debt (mrq) 5.2B USD
Total Debt/Equity (mrq) 23.63 USD
Current Ratio (mrq) 2.701
Book Value Per Share (mrq) 44.388

Cash Flow Statement

Operating Cash Flow (ttm) 2.12B USD
Levered Free Cash Flow (ttm) 1.18B USD

Profile of Alcon

Country United States
State N/A
City Geneva
Address Chemin de Blandonnet 8
ZIP 1214
Phone 41 589 112 110
Website https://www.alcon.com
Industry Medical Instruments & Supplies
Sector(s) Healthcare
Full Time Employees 25000

Alcon Inc. researches, develops, manufactures, distributes, and sells eye care products worldwide. It operates through two segments, Surgical and Vision Care. The company offers equipment, instrumentation and diagnostics, intraocular lenses (IOLs), and other implantables; and consumables, including viscoelastics, surgical solutions, incisional instruments, surgical custom packs, and other products for surgical procedures. Its cataract products include Centurion vision system, LenSx laser system, Verion reference unit and Verion digital marker, ARGOS biometer, SMARTCATARACT health platform, NGENUITY 3D visualization system, LuxOR surgical ophthalmic microscope, and ORA system for intra-operative measurements; and implantable products, including monofocal, Toric, and Presbyopia-Correcting IOLs, as well as delivery systems, such as AutonoMe and UltraSert. In addition, it provides Custom Pak surgical procedure packs vitreoretinal products comprising constellation vision systems, procedure packs, lasers and hand-held microsurgical instruments, grieshaber, MIVS instruments, scissors, forceps and micro-instruments, medical grade vitreous tamponades, and Hypervit vitrectomy probes; and refractive surgery products, including WaveLight and Contoura Vision used for LASIK refractive procedure. Further, the company offers daily disposable, reusable, and color-enhancing contact lenses; ocular health products, such as dry eye, ocular allergies, glaucoma, and contact lens care, as well as ocular vitamins and redness relievers. The company was formerly known as Alcon Universal S.A. and changed its name to Alcon Inc. in December 2001. Alcon Inc. was founded in 1945 and is headquartered in Geneva, Switzerland.

Q&A For Alcon Stock

What is a current ALC stock price?

Alcon ALC stock price today per share is 73.89 USD.

How to purchase Alcon stock?

You can buy ALC shares on the NYSE exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Alcon?

The stock symbol or ticker of Alcon is ALC.

Which industry does the Alcon company belong to?

The Alcon industry is Medical Instruments & Supplies.

How many shares does Alcon have in circulation?

The max supply of Alcon shares is 499.57M.

What is Alcon Price to Earnings Ratio (PE Ratio)?

Alcon PE Ratio is 34.20833200 now.

What was Alcon earnings per share over the trailing 12 months (TTM)?

Alcon EPS is 2.16 USD over the trailing 12 months.

Which sector does the Alcon company belong to?

The Alcon sector is Healthcare.

Alcon ALC included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NYSE Composite Index NYA 21459.58 USD
+0.04
21350.03 USD 21510.64 USD
✨New! Portfolio🚀